106 related articles for article (PubMed ID: 2702771)
1. Cyclosporin A enhances elimination of intracellular L. major parasites by murine macrophages.
Bogdan C; Streck H; Röllinghoff M; Solbach W
Clin Exp Immunol; 1989 Jan; 75(1):141-6. PubMed ID: 2702771
[TBL] [Abstract][Full Text] [Related]
2. Suppressive effect of cyclosporin A on the development of Leishmania tropica-induced lesions in genetically susceptible BALB/c mice.
Solbach W; Forberg K; Kammerer E; Bogdan C; Röllinghoff M
J Immunol; 1986 Jul; 137(2):702-7. PubMed ID: 3487578
[TBL] [Abstract][Full Text] [Related]
3. Intracellular destruction of Leishmania donovani and Leishmania tropica amastigotes by activated macrophages: dissociation of these microbicidal effector activities in vitro.
Hockmeyer WT; Walters D; Gore RW; Williams JS; Fortier AH; Nacy CA
J Immunol; 1984 Jun; 132(6):3120-5. PubMed ID: 6725948
[TBL] [Abstract][Full Text] [Related]
4. Macrophage activation to kill Leishmania tropica: defective intracellular killing of amastigotes by macrophages elicited with sterile inflammatory agents.
Hoover DL; Nacy CA
J Immunol; 1984 Mar; 132(3):1487-93. PubMed ID: 6363543
[TBL] [Abstract][Full Text] [Related]
5. Leishmania major interferes with antigen presentation by infected macrophages.
Fruth U; Solioz N; Louis JA
J Immunol; 1993 Mar; 150(5):1857-64. PubMed ID: 8436821
[TBL] [Abstract][Full Text] [Related]
6. A spectrum in the susceptibility of leishmanial strains to intracellular killing by murine macrophages.
Scott P; Sher A
J Immunol; 1986 Feb; 136(4):1461-6. PubMed ID: 3511147
[TBL] [Abstract][Full Text] [Related]
7. Presentation of the protective parasite antigen LACK by Leishmania-infected macrophages.
Prina E; Lang T; Glaichenhaus N; Antoine JC
J Immunol; 1996 Jun; 156(11):4318-27. PubMed ID: 8666803
[TBL] [Abstract][Full Text] [Related]
8. Cyclosporin A-mediated killing of Leishmania major by macrophages is independent of reactive nitrogen and endogenous TNF-alpha and is not inhibited by IL-10 and 13.
Meissner U; Jüttner S; Röllinghoff M; Gessner A
Parasitol Res; 2003 Feb; 89(3):221-7. PubMed ID: 12541065
[TBL] [Abstract][Full Text] [Related]
9. Interleukin 1alpha activity of peritoneal and bone marrow macrophages infected with Leishmania major and Leishmania donovani in vitro.
Bersudsky M; Apte RN; El-On J
Exp Parasitol; 2000 Mar; 94(3):150-7. PubMed ID: 10831379
[TBL] [Abstract][Full Text] [Related]
10. Passive transfer of Leishmania lipopolysaccharide confers parasite survival in macrophages.
Handman E; Schnur LF; Spithill TW; Mitchell GF
J Immunol; 1986 Dec; 137(11):3608-13. PubMed ID: 3782793
[TBL] [Abstract][Full Text] [Related]
11. Leishmania major and Leishmania tropica: I the in vitro effects of an immunomodulator, S2-Complex.
Al-Mulla Hummadi YM; Najim RA; Al-Bashir NM
Exp Parasitol; 2005 Sep; 111(1):47-54. PubMed ID: 15970286
[TBL] [Abstract][Full Text] [Related]
12. Distinctive cellular immunity in genetically susceptible BALB/c mice recovered from Leishmania major infection or after subcutaneous immunization with killed parasites.
Liew FY; Dhaliwal JS
J Immunol; 1987 Jun; 138(12):4450-6. PubMed ID: 3295049
[TBL] [Abstract][Full Text] [Related]
13. Murine cutaneous leishmaniasis: resistance correlates with the capacity to generate interferon-gamma in response to Leishmania antigens in vitro.
Sadick MD; Locksley RM; Tubbs C; Raff HV
J Immunol; 1986 Jan; 136(2):655-61. PubMed ID: 3079789
[TBL] [Abstract][Full Text] [Related]
14. Macrophage activation for antileishmanial defense by an apparently novel mechanism.
Wyler DJ; Beller DI; Sypek JP
J Immunol; 1987 Feb; 138(4):1246-9. PubMed ID: 3100630
[TBL] [Abstract][Full Text] [Related]
15. Leishmania antigens presented by GM-CSF-derived macrophages protect susceptible mice against challenge with Leishmania major.
Doherty TM; Coffman RL
J Immunol; 1993 Jun; 150(12):5476-83. PubMed ID: 8515072
[TBL] [Abstract][Full Text] [Related]
16. The third component of complement (C3) is responsible for the intracellular survival of Leishmania major.
Mosser DM; Edelson PJ
Nature; 1987 May 28-Jun 3; 327(6120):329-31. PubMed ID: 3035377
[TBL] [Abstract][Full Text] [Related]
17. Macrophage activation to kill Leishmania tropica: characterization of P/J mouse macrophage defects for lymphokine-induced antimicrobial activities against Leishmania tropica amastigotes.
Nacy CA; Meltzer MS; Fortier AH
J Immunol; 1984 Dec; 133(6):3344-50. PubMed ID: 6491291
[TBL] [Abstract][Full Text] [Related]
18. Activation of the alternative complement pathway by Leishmania promastigotes: parasite lysis and attachment to macrophages.
Mosser DM; Edelson PJ
J Immunol; 1984 Mar; 132(3):1501-5. PubMed ID: 6363545
[TBL] [Abstract][Full Text] [Related]
19. Determination of intracellular efficacies of azithromycin against Leishmania major infection in human neutrophils in vitro.
Tanyuksel M; Bas AL; Araz E; Aybay C
Cell Biochem Funct; 2003 Mar; 21(1):93-6. PubMed ID: 12579528
[TBL] [Abstract][Full Text] [Related]
20. Macrophage activation for microbicidal activity against Leishmania major: inhibition of lymphokine activation by phosphatidylcholine-phosphatidylserine liposomes.
Gilbreath MJ; Nacy CA; Hoover DL; Alving CR; Swartz GM; Meltzer MS
J Immunol; 1985 May; 134(5):3420-5. PubMed ID: 3980997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]